<p><b>A</b>) Stable downregulation of tuberin in C3H-10T1/2 pre-pericytes results in increased phosphorylation of ribosomal protein S6, as expected. Treatment with Rapamycin (20 nM, 24 h) inhibits phosphorylation of S6. <b>B</b>) Downregulation of TSC2 in C3H-10T1/2 cells does not affect miR-21 expression. Inhibition of mTORC1 with Rapamycin induces ∼2-fold increase in miR-21 expression in both control shRNA and TSC2 shRNA cells. Bars represent the mean of two biologic replicates +/− SD. * p<0.05. <b>C</b>) LAM patient-derived cells (621-101), TSC2-null rat uterine leiomyoma-derived cells (ELT3), TSC2-null mouse embryonic fibroblasts (MEFs), HEK293 and lung adenocarcinoma (A549) cells were treated with Rapamycin 20 nM vs Control for 24 h. R...
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by suppressing the target...
mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly activate...
<p>Rapamycin-regulated miRNA in LAM patient-derived cells identified by the Exiqon Array (Fold Chang...
mTORC1 hyperactivation drives the multi-organ hamartomatous disease tuberous sclerosis complex (TSC)...
<p>TSC2−/− cells were treated with Rapamycin 20 nM or DMSO for 24 hr and miRNA expression was assess...
Lymphangioleiomyomatosis (LAM), a multisystem disease of women, is manifest by the proliferation of ...
<p>ACHN cells were transfected with miR-21 Sponge or vector. The cell lysates were immunoblotted wit...
The aim of this study was to assess the potential implication of microRNA on tuberous sclerosis (TSC...
<p><b>A</b>) Western blot analysis of 621-101 cells treated with DMSO (lane 1), Rapamycin (20 nM, 24...
The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of cell growth that is...
The mammalian target of rapamycin (mTOR) is a major regulator of cell growth, motility and angiogene...
Background: Mammalian target of rapamycin (mTOR) inhibitors exert significant antitumor effects on s...
mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly activate...
<div><p>mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly ...
mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly activate...
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by suppressing the target...
mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly activate...
<p>Rapamycin-regulated miRNA in LAM patient-derived cells identified by the Exiqon Array (Fold Chang...
mTORC1 hyperactivation drives the multi-organ hamartomatous disease tuberous sclerosis complex (TSC)...
<p>TSC2−/− cells were treated with Rapamycin 20 nM or DMSO for 24 hr and miRNA expression was assess...
Lymphangioleiomyomatosis (LAM), a multisystem disease of women, is manifest by the proliferation of ...
<p>ACHN cells were transfected with miR-21 Sponge or vector. The cell lysates were immunoblotted wit...
The aim of this study was to assess the potential implication of microRNA on tuberous sclerosis (TSC...
<p><b>A</b>) Western blot analysis of 621-101 cells treated with DMSO (lane 1), Rapamycin (20 nM, 24...
The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of cell growth that is...
The mammalian target of rapamycin (mTOR) is a major regulator of cell growth, motility and angiogene...
Background: Mammalian target of rapamycin (mTOR) inhibitors exert significant antitumor effects on s...
mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly activate...
<div><p>mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly ...
mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly activate...
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by suppressing the target...
mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly activate...
<p>Rapamycin-regulated miRNA in LAM patient-derived cells identified by the Exiqon Array (Fold Chang...